- Home
- Equipment
- north america
- biomanufacturer
Show results for
Refine by
Biomanufacturer Equipment Supplied In North America
7 equipment items found
by:National Resilience, Inc. based inSan Diego, CALIFORNIA (USA)
Now more than ever, global vaccine innovators need a biomanufacturing partner with the ability to adapt skillfully and the capacity to scale rapidly. Enter ...
Manufactured by:BioFactura, Inc. based inFrederick, MARYLAND (USA)
BioFactura develops and commercializes high-value biosimilars (i.e., follow-on biologics or generic biopharmaceuticals) using its patented StableFastTM Biomanufacturing Platform, the optimal choice for bringing these drug to market with faster, lower cost, superior-quality manufacture. The global biosimilars market is projected to grow from $4.5B in 2017 to over $23B by 2023 with ...
Manufactured by:BioSpectra, Inc. based inBangor, PENNSYLVANIA (USA)
It is synthesized from non-animal derived raw materials under appropriate controls for use in Pharm and Bio-Pharm production under a fully validated GMP manufacturing system. It is also suitable for cell culture media component for the commercial biomanufacturer of therapeutic recombinant proteins and monoclonal antibodies. ...
Manufactured by:Sealed Air Corporation based inCharlotte, NORTH CAROLINA (USA)
Our single-use films are designed specifically for the biopharmaceutical ...
Manufactured by:Catalent, Inc based inSomerset, NEW JERSEY (USA)
The biologics market is experiencing high growth. However, the path to clinic for biologics is complex, requiring a substantial amount of time and resources to ensure success. Sponsor companies are looking for an “all of the above” solution, where they don’t have to trade speed for risk while managing multiple development partners. ...
by:Aspect Biosystems Ltd. based inVancouver, BRITISH COLUMBIA (CANADA)
Accurately recreate complex and functional physiological structures for medical research, therapeutic discovery and regenerative medicine using the Aspect ...
Manufactured by:Humacyte, Inc. based inDurham, NORTH CAROLINA (USA)
Humacyte’s platform technology has the potential to change the lives of countless people around the world by overcoming the current limitations in existing standards of care. We are leveraging our scalable technology platform to develop bioengineered human tissues for use in the treatment of diseases and conditions across a wide range of clinical needs. We are initially using our ...